AIP
AGL icon

Ameritas Investment Partners’s Agilon Health AGL Stock Holding History

Ameritas Investment Partners’s Portfolio AGL Stock Details AGL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$9.55K Sell
1,208
-1
-0.1% -$16 ﹤0.01% 2884
2025
Q4 		$20.8K Hold
1,209
– – ﹤0.01% 2617
2025
Q3 		$31.1K Hold
1,209
– – ﹤0.01% 2459
2025
Q2 		$69.5K Hold
1,209
– – ﹤0.01% 1976
2025
Q1 		$131K Hold
1,209
– – ﹤0.01% 1527
2024
Q4 		$57.4K Hold
1,209
– – ﹤0.01% 2099
2024
Q3 		$119K Hold
1,209
– – ﹤0.01% 1675
2024
Q2 		$198K Buy
+1,209
New +$172K 0.01% 1271

Other funds holding AGL

CDR
Clayton Dubilier & Rice New York $536M AUM 0.63% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
NPCM
North Peak Capital Management New York $601M AUM 0.2% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return
Jacobs Levy Equity Management
Jacobs Levy Equity Management Florham Park, New Jersey $23.8B AUM 25.4% 1-Year Est. Return

Ameritas Investment Partners's AGL Position: Q1 2026 in Review

Ameritas Investment Partners reduced its Agilon Health (AGL) stake by 0.08% in Q1 2026, selling an estimated $16 and leaving 1,208 shares worth $9.55K. The position accounts for ﹤0.01% of the portfolio, ranked #2884.

Ameritas Investment Partners first reported a position in AGL in Q2 2024 and has held it in 8 quarters since. The position peaked at $198K in Q2 2024. 97 funds tracked by Wall St. Rank hold AGL as of Q1 2026.

  • Ameritas Investment Partners held 1,208 shares of Agilon Health worth $9.55K as of Q1 2026.
  • Ameritas Investment Partners sold 1 Agilon Health share in Q1 2026, an estimated $16.
  • Agilon Health made up ﹤0.01% of Ameritas Investment Partners's portfolio in Q1 2026, its #2884 holding.
  • Ameritas Investment Partners first reported a position in Agilon Health in Q2 2024 and has held it in 8 quarters since.
  • Ameritas Investment Partners's Agilon Health position peaked at $198K in Q2 2024.
  • 97 funds tracked by Wall St. Rank held Agilon Health as of Q1 2026.

Based on Ameritas Investment Partners's 13F filing for Q1 2026, filed 13 May 2026.